Addictions Management Systems

Addictions Management Systems (AMS) is a healthcare services company specializing in the treatment of opioid use disorder through Medication-Assisted Treatment (MAT) programs. The company operates a network of outpatient clinics that provide FDA-approved medications, such as methadone and buprenorphine, integrated with clinical counseling and behavioral health services. AMS focuses on supporting individuals struggling with addiction to heroin and prescription opioid analgesics by offering comprehensive, evidence-based recovery plans. In November 2017, the company was acquired by BayMark Health Services, a major provider of opioid addiction treatment in North America, and its facilities were integrated into the BayMark network.